Deals Of The Week Ponders Project Financing
Executive Summary
GSK has been out ahead of other big pharmas when it comes to investing in venture funds. Its deal with Avalon Ventures adds a new twist – investing as a partner rather than an LP and creating single-asset companies. Plus other notable deals involving Merck, AstraZeneca, Opko Health and more . . .